🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study was to investigate the single-dose relative bio...
Status
Completed
Location
PRACS Institute, Ltd.
Start Date
2002-12
Trial ID
NCT00650481
Treatments Being Tested
The objective of this study was to investigate the single-dose relative bio...
Status
Completed
Location
Kendle International Inc.
Start Date
2002-07
Trial ID
NCT00649727
Treatments Being Tested
To evaluate efficacy of tolterodine extended release formulation compared w...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-05
Trial ID
NCT00139724
Treatments Being Tested
Patients with overactive bladder are often treated with tolterodine, a medi...
Status
Completed
Location
Radiant Research, Inc.
Start Date
2011-05
Trial ID
NCT01302054
Treatments Being Tested
This study will evaluate the safety and effectiveness of an anticholinergic...
Status
Completed
Location
Watson Investigational Site
Start Date
2004-12
Trial ID
NCT00224016
Treatments Being Tested
This study will evaluate the pharmacologic effects of exposure to darifenac...
Status
Completed
Location
Investigative Site
Start Date
2006-11
Trial ID
NCT00413790
Treatments Being Tested
The objective of this study was to investigate the single-dose relative bio...
Status
Completed
Location
PRACS Institute, Ltd.
Start Date
2002-12
Trial ID
NCT00648843
Treatments Being Tested
The study is intended to test the safety, tolerability, efficacy of two dos...
Status
Completed
Location
Multiple Locations
Start Date
2008-04-25
Trial ID
NCT00688688
Treatments Being Tested
The purpose of this Phase III study is to evaluate the efficacy and safety ...
Status
Completed
Location
Beijing Chaoyang Hospital
Start Date
2010-01
Trial ID
NCT01512004
Treatments Being Tested
This study will evaluate the pharmacologic effects of exposure to darifenac...
Status
Completed
Location
Investigative Site
Start Date
2008-05
Trial ID
NCT00703703
Treatments Being Tested